CEO Summary: Pre-authorization of expensive genetic and molecular tests is a threat to local clinical laboratories and pathology groups if payers exclude them from provider networks in favor of labs which bid the lowest prices. But one major healthcare corporation believes there is now an opportunity for clinical labs and pathology groups to deliver added […]
Systems Approach For Pre-Authorization Of Genetic Tests
Boosting the Value Labs Deliver to Doctors and Payers
- By Robert Michel
- > From the Volume XVII No. 14 - October 4, 2010 Issue
- Tags: aco, cap, Capitation, clinical lab, clinical laboratories, Clinical Laboratory, clinical labs, clinical workflow, cpt, dark report, diagnostic testing, ehi, ehr, electronic health record, Electronic health record (EHR), electronic medical record, electronic medical record system, emr, emr system, emr systems, Fee-for-service, genetic test, genetic testing, genetic testing registry, genetic tests, genomics, healthcare reform, hie, informatics, integrated informatics, lab administrator, lab it, lab test, lab test utilization, lab testing, lab tests, laboratories, laboratory administrator, laboratory information, laboratory information system, laboratory test, laboratory testing, laboratory tests, management systems, molecular assay, molecular assays, molecular lab, molecular laboratory, molecular testing, molecular tests, NY labs, pathologists, Pathology group, pathology groups, pathology practice, personalized medicine, pharmacogenomics, test utilization, the dark report, the laboratory, utilization management
